In this video, Hayley explains the disruptive impact that heavy menstrual bleeding has had on her life, and her experience with different treatments. She shares her advice for other women who experience heavy menstrual bleeding.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard includes links to resources that may help healthcare services and clinicians to implement the standard. These resources are listed under the relevant quality statements below.
Clinicians, consumers and healthcare services have been consulted during the development of the Standard.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard has been endorsed by the following organisations:
The quality statements describe the expected standard for key components of patient care. By describing what each statement means, they support:
These information sheets explain what the clinical care standard means for consumer, clinicians and healthcare services.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains
The standard contains eight quality statements to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.
Psychotropic medicines are used mainly to treat mental health conditions like schizophrenia, anxiety, depression, and bipolar disorder. Some psychotropic medicines can also be used for health conditions such as pain or sleeping problems.